IL6 and colorectal cancer: Nevertheless, others have reported that supplementation of VSL3# with anti-inflammatory drug balsalazide in mice with colorectal cancer induced by azoxymethane/dextran sodium sulfate reduces tumor burden in association with increasing Bax/Bcl-2 ratio and lowers IL6/STAT-3 signaling [259].